NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Thursday that its second quarter revenues rose 64 percent, driven by strength in sales of its XT-8 eSensor molecular diagnostics system and its infectious disease menu.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.